Unknown PHASE3 INTERVENTIONAL 2-arm NCT04323345

Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus

The Efficacy of Natural Honey in Patients Infected With Novel Coronavirus (COVID-19) : A Randomized, Controlled ,Single Masked , Investigator Initiated, Multi-center Trial

Sponsor: Misr University for Science and Technology

Conditions COVID-19

Interventions Natural Honey Standard Care

Updated 6 times since 2020 Last updated: Apr 18, 2020 Started: Apr 15, 2020 Primary completion: Dec 15, 2020 Completion: Jan 15, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates COVID-19 and is currently ongoing. Misr University for Science and Technology leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
May 2022 — Jul 2024 [monthly]

Unknown Status PHASE3

Status: Recruiting → Unknown Status
Jan 2021 — May 2022 [monthly]

Recruiting PHASE3
May 2020 — Jan 2021 [monthly]

Recruiting PHASE3

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Apr 2020 — May 2020 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Misr University for Science and Technology

Data source: Misr University for Science and Technology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cairo, Egypt